Back
ESC Professional Premium Access

Endothelial dysfunction due to decreased nitric oxide bioavailability in dysglycaemic subjects and first-degree relatives of type 2 diabetic patients

Session: Diabetes and the heart 1
Topic: Metabolic Syndrome, Insulin, Insulin Resistance
Speaker: Doctor I. Ikonomidis (Athens, GR)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Ignatios Ikonomidis

National & Kapodistrian University of Athens, Athens (Greece)
5 presentations
3 followers

4 more presentations in this session

Diabetes and coronary risk equivalency - a population-based cohort study from Western Denmark

Speaker: Doctor K. Olesen (Aarhus, DK)

Access
Abstract
Slides
Thumbnail

Measures of insulin resistance as a screening tool for dysglycaemia in patients with coronary artery disease. A report from the EUROASPIRE V population.

Speaker: Doctor G. Ferrannini (Stockholm, SE)

Access
Abstract
Slides
Thumbnail

Quantity of adipose tissue and adipose tissue dysfunction and the risk of cancer in individuals at high risk of cardiovascular disease

Speaker: Ms M. Helmink (Utrecht, NL)

Access
Abstract
Slides
Thumbnail

Metabolic syndrome and heart failure: 40 years follow up results of the Seven Countries Study

Speaker: Assistant Professor B. Parapid (Belgrade, RS)

Access
Abstract
Slides
Thumbnail

Access the full session

Diabetes and the heart 1

Speakers: Doctor I. Ikonomidis, Doctor K. Olesen, Doctor G. Ferrannini, Ms M. Helmink, Assistant Professor B. Parapid
Access
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb